Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Nitroglycerin Tablet vs Capsule NTG1523
NCT03777605Phase 4Unknown
- Sponsor
- Kolding Sygehus
- Start
- Dec 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nitroglycerin in angina pectoris (2 arms), sponsored by Kolding Sygehus. Primary endpoint: Peak Plasma Concentration of Nitroglycerin at 5 weeks. Status: unknown.
02
Drugs
nitroglycerin
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT03777605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03777605.